Finance Novartis Buys MorphoSys for €2.7 Billion to Get Cancer DrugsFebruary 6, 20240 (Bloomberg) — Novartis AG agreed to purchase MorphoSys AG for €2.7 billion ($2.9 billion) because the Swiss pharma firm begins…
